A coronavirus vaccine could be available sooner than you might think.
News & Analysis: BioNTech SE
These two biotech companies have exciting projects in the works, but are still too risky to touch.
Treatments, vaccines, or both?
One is producing large numbers of COVID-19 diagnostic tests; the other may be among the first companies to get a coronavirus vaccine approved.
The pharmaceutical giant just laid out a timetable for when it expects to be able to meet the FDA's EUA application requirements for BNT162.
The timing is right for two popular Robinhood stocks with promising COVID-19 programs.
Here Are the Only 2 Coronavirus Vaccines That Could Meet the FDA's Authorization Guidelines by Year-End
It's a process of elimination.
News from a peer coronavirus vaccine developer added to recent bullishness on the German company.
There's little doubt that COVID-19 vaccines will save many lives, but that doesn't mean investors will be rewarded.
Health Canada will determine BNT162b2's suitability for approval as clinical trial data comes in.